Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score‐matched analysis

Abstract Aims The optimal timing for prescribing guideline‐directed medical therapy (GDMT) in patients with heart failure with reduced ejection fraction (HFrEF) during acute decompensated heart failure (ADHF) remains uncertain. This study evaluated the real‐world impact of early in‐hospital quadrupl...

Full description

Saved in:
Bibliographic Details
Main Authors: Luis E. Echeverría, Lyda Z. Rojas, Angie Yarlady Serrano‐García, Daniel Botero, Karen Andrea García‐Rueda, Ángela Torres‐Bustamante, Diana Ivonne Cañón‐Gómez, Juan Sebastián Salcedo, Alexandra Hurtado‐Ortiz, Jaime A. Rodríguez, Sergio A. Gómez‐Ochoa
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.15286
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839617907560022016
author Luis E. Echeverría
Lyda Z. Rojas
Angie Yarlady Serrano‐García
Daniel Botero
Karen Andrea García‐Rueda
Ángela Torres‐Bustamante
Diana Ivonne Cañón‐Gómez
Juan Sebastián Salcedo
Alexandra Hurtado‐Ortiz
Jaime A. Rodríguez
Sergio A. Gómez‐Ochoa
author_facet Luis E. Echeverría
Lyda Z. Rojas
Angie Yarlady Serrano‐García
Daniel Botero
Karen Andrea García‐Rueda
Ángela Torres‐Bustamante
Diana Ivonne Cañón‐Gómez
Juan Sebastián Salcedo
Alexandra Hurtado‐Ortiz
Jaime A. Rodríguez
Sergio A. Gómez‐Ochoa
author_sort Luis E. Echeverría
collection DOAJ
description Abstract Aims The optimal timing for prescribing guideline‐directed medical therapy (GDMT) in patients with heart failure with reduced ejection fraction (HFrEF) during acute decompensated heart failure (ADHF) remains uncertain. This study evaluated the real‐world impact of early in‐hospital quadruple GDMT prescription in ADHF patients with HFrEF. Methods and Results In this retrospective cohort study using the Institutional aCute descompensAted heaRt failUre regiStry (ICARUS), we analysed 2051 HFrEF patients (71% male, median age 68 years) hospitalized for ADHF between June 2022 and March 2024. Early quadruple therapy was defined as the prescription of beta‐blockers, angiotensin‐converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs)/angiotensin receptor–neprilysin inhibitors (ARNIs), mineralocorticoid receptor antagonists (MRAs) and sodium–glucose cotransporter‐2 inhibitors (SGLT2is) within 48 h of admission. Among included patients, 898 (43.8%) received early quadruple therapy. Using optimal full matching propensity score methodology, early quadruple therapy was associated with lower 30 day mortality/rehospitalization [relative risk (RR) 0.73; 95% confidence interval (CI) 0.55–0.97, P = 0.028], reduced in‐hospital mortality (RR 0.29; 95% CI 0.15–0.56, P < 0.001) and shorter hospital stay (β = −2.65 days; 95% CI −3.67 to −1.63, P < 0.001). Patients receiving early quadruple therapy showed higher rates of GDMT continuation at discharge (RR 3.82; 95% CI 3.01–4.86, P < 0.001). Conclusions In this HFrEF cohort, early initiation of comprehensive GDMT during ADHF hospitalization was associated with improved clinical outcomes. Future randomized trials including patients across the full spectrum of ejection fraction are needed to validate these findings and determine their applicability to other heart failure phenotypes.
format Article
id doaj-art-7b86d4f1b7af49dbb5e89cb455da2be2
institution Matheson Library
issn 2055-5822
language English
publishDate 2025-08-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj-art-7b86d4f1b7af49dbb5e89cb455da2be22025-07-24T10:14:12ZengWileyESC Heart Failure2055-58222025-08-011242814282610.1002/ehf2.15286Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score‐matched analysisLuis E. Echeverría0Lyda Z. Rojas1Angie Yarlady Serrano‐García2Daniel Botero3Karen Andrea García‐Rueda4Ángela Torres‐Bustamante5Diana Ivonne Cañón‐Gómez6Juan Sebastián Salcedo7Alexandra Hurtado‐Ortiz8Jaime A. Rodríguez9Sergio A. Gómez‐Ochoa10Heart Failure and Transplant Clinic Fundación Cardiovascular de Colombia Floridablanca ColombiaResearch Center Fundación Cardiovascular de Colombia Floridablanca ColombiaHeart Failure and Transplant Clinic Fundación Cardiovascular de Colombia Floridablanca ColombiaHeart Failure and Transplant Clinic Fundación Cardiovascular de Colombia Floridablanca ColombiaHeart Failure and Transplant Clinic Fundación Cardiovascular de Colombia Floridablanca ColombiaHeart Failure and Transplant Clinic Fundación Cardiovascular de Colombia Floridablanca ColombiaDepartment of Cardiology Fundación Cardiovascular de Colombia Floridablanca ColombiaDepartment of Cardiology Fundación Cardiovascular de Colombia Floridablanca ColombiaEpidemiology Unit Fundación Cardiovascular de Colombia Floridablanca ColombiaHeart Failure and Transplant Clinic Fundación Cardiovascular de Colombia Floridablanca ColombiaHeart Failure and Transplant Clinic Fundación Cardiovascular de Colombia Floridablanca ColombiaAbstract Aims The optimal timing for prescribing guideline‐directed medical therapy (GDMT) in patients with heart failure with reduced ejection fraction (HFrEF) during acute decompensated heart failure (ADHF) remains uncertain. This study evaluated the real‐world impact of early in‐hospital quadruple GDMT prescription in ADHF patients with HFrEF. Methods and Results In this retrospective cohort study using the Institutional aCute descompensAted heaRt failUre regiStry (ICARUS), we analysed 2051 HFrEF patients (71% male, median age 68 years) hospitalized for ADHF between June 2022 and March 2024. Early quadruple therapy was defined as the prescription of beta‐blockers, angiotensin‐converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs)/angiotensin receptor–neprilysin inhibitors (ARNIs), mineralocorticoid receptor antagonists (MRAs) and sodium–glucose cotransporter‐2 inhibitors (SGLT2is) within 48 h of admission. Among included patients, 898 (43.8%) received early quadruple therapy. Using optimal full matching propensity score methodology, early quadruple therapy was associated with lower 30 day mortality/rehospitalization [relative risk (RR) 0.73; 95% confidence interval (CI) 0.55–0.97, P = 0.028], reduced in‐hospital mortality (RR 0.29; 95% CI 0.15–0.56, P < 0.001) and shorter hospital stay (β = −2.65 days; 95% CI −3.67 to −1.63, P < 0.001). Patients receiving early quadruple therapy showed higher rates of GDMT continuation at discharge (RR 3.82; 95% CI 3.01–4.86, P < 0.001). Conclusions In this HFrEF cohort, early initiation of comprehensive GDMT during ADHF hospitalization was associated with improved clinical outcomes. Future randomized trials including patients across the full spectrum of ejection fraction are needed to validate these findings and determine their applicability to other heart failure phenotypes.https://doi.org/10.1002/ehf2.15286acute decompensated heart failureGDMTheart failuremortalityoutcomes
spellingShingle Luis E. Echeverría
Lyda Z. Rojas
Angie Yarlady Serrano‐García
Daniel Botero
Karen Andrea García‐Rueda
Ángela Torres‐Bustamante
Diana Ivonne Cañón‐Gómez
Juan Sebastián Salcedo
Alexandra Hurtado‐Ortiz
Jaime A. Rodríguez
Sergio A. Gómez‐Ochoa
Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score‐matched analysis
ESC Heart Failure
acute decompensated heart failure
GDMT
heart failure
mortality
outcomes
title Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score‐matched analysis
title_full Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score‐matched analysis
title_fullStr Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score‐matched analysis
title_full_unstemmed Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score‐matched analysis
title_short Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score‐matched analysis
title_sort early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction a propensity score matched analysis
topic acute decompensated heart failure
GDMT
heart failure
mortality
outcomes
url https://doi.org/10.1002/ehf2.15286
work_keys_str_mv AT luiseecheverria earlyprescriptionofquadrupletherapyinacutedecompensatedheartfailurewithreducedejectionfractionapropensityscorematchedanalysis
AT lydazrojas earlyprescriptionofquadrupletherapyinacutedecompensatedheartfailurewithreducedejectionfractionapropensityscorematchedanalysis
AT angieyarladyserranogarcia earlyprescriptionofquadrupletherapyinacutedecompensatedheartfailurewithreducedejectionfractionapropensityscorematchedanalysis
AT danielbotero earlyprescriptionofquadrupletherapyinacutedecompensatedheartfailurewithreducedejectionfractionapropensityscorematchedanalysis
AT karenandreagarciarueda earlyprescriptionofquadrupletherapyinacutedecompensatedheartfailurewithreducedejectionfractionapropensityscorematchedanalysis
AT angelatorresbustamante earlyprescriptionofquadrupletherapyinacutedecompensatedheartfailurewithreducedejectionfractionapropensityscorematchedanalysis
AT dianaivonnecanongomez earlyprescriptionofquadrupletherapyinacutedecompensatedheartfailurewithreducedejectionfractionapropensityscorematchedanalysis
AT juansebastiansalcedo earlyprescriptionofquadrupletherapyinacutedecompensatedheartfailurewithreducedejectionfractionapropensityscorematchedanalysis
AT alexandrahurtadoortiz earlyprescriptionofquadrupletherapyinacutedecompensatedheartfailurewithreducedejectionfractionapropensityscorematchedanalysis
AT jaimearodriguez earlyprescriptionofquadrupletherapyinacutedecompensatedheartfailurewithreducedejectionfractionapropensityscorematchedanalysis
AT sergioagomezochoa earlyprescriptionofquadrupletherapyinacutedecompensatedheartfailurewithreducedejectionfractionapropensityscorematchedanalysis